CrossVision IP Insights

Patent Intelligence,
Practitioner-Grade

In-depth analysis of USPTO and EPO developments, prosecution strategy, and cross-border IP practice —written for attorneys, patent agents, and corporate IP counsel.

58 articles

All Articles

Patent Risk / FTO

FTO Is Expensive. Can Companies Do an Initial Screening In-House?

A disciplined first-pass FTO screen can reduce cost and surface risk early—but only if product decomposition, claim mapping, legal-status checks, and escalation are kept separate from a formal legal opinion.

Patent AI

If AI Citation Errors Can Discipline Patent Lawyers, What Happens When Patent Examiners Get It Wrong?

Patent practitioners can face public discipline for unverified AI citations. Using the USPTO as a case study, this article asks what accountability, correction, and quality-review mechanisms apply when patent examiners get the underlying source wrong.

Patent Risk / FTO

When a Battery Cell Triggers a Section 337 Investigation: The Supply-Chain Blind Spot in FTO

The USITC’s battery investigation shows why product FTO should follow the real supply chain—from critical components and subassemblies to finished products and importers.

Office Action

Why “Different Field” Is Usually Not Enough to Defeat a §103 Rejection

A §103 reference must be analogous art, but a different industry label does not end the inquiry. The real analysis asks whether the reference is in the same field of endeavor or reasonably pertinent to the inventor’s problem.

Patent Risk / FTO

What Makes an FTO Report Actually Useful to R&D Teams?

A 100-page FTO report can still leave engineers asking what to change. Useful FTO work connects each risk to product facts, claim limitations, missing information, and concrete next actions.

Patent AI

AI Will Not Replace Patent Lawyers First—It Will Replace Standardized Patent Work

The near-term AI disruption in patent practice is less about eliminating experienced professionals than compressing the value of work that can be standardized, generated, and checked at scale.

Patent Risk / FTO

FTO Is Not About Zero Risk: It Is About Whether the Remaining Risk Is Worth Taking

A responsible FTO rarely says “no risk.” Its real value is to make patent risk visible, distinguish legal exposure from commercial exposure, and show management which risks can be designed around, licensed, monitored, or consciously accepted.

Patent AI

Why Chinese Software and AI Patent Applications Often Need Re-Drafting Before U.S. Filing

Accurate translation is not the same as U.S. filing readiness. Software and AI applications often need pre-filing adaptation for §101, §112, claim support, and future prosecution flexibility.

Patent Risk / FTO

Why Removing One Component Does Not Automatically Mean You Have Designed Around a Patent

A missing component can defeat literal infringement of a particular claim, but a defensible design-around also requires claim construction, equivalents, prosecution history, other claims, and product evidence.

Patent AI

If AI Turns Three Hours of Legal Work into 30 Minutes, What Should the Client Pay?

AI can compress legal work, but hourly billing still tracks actual time. The harder question is how patent professionals should price expertise, review, and accountable outcomes.

Patent Risk / FTO

How Much FTO Is Enough? A Cost-Risk Framework for Companies

FTO should not be one-size-fits-all. A practical framework helps companies match search and analysis depth to product value, market exposure, design stage, supply chain, and decision risk.

Patent Risk / FTO

Patentability Search vs. FTO: Why a Novelty Search Does Not Clear a Product for Launch

Patentability and FTO searches may use the same databases, but they answer different legal questions. A patentable improvement can still infringe a broader earlier patent.

USPTO Practice

Why More Embodiments Do Not Necessarily Cure U.S. Written-Description and Enablement Problems

Under §112(a), volume is not the same as support. Written description and enablement turn on what the specification actually teaches relative to the scope of the claims.

U.S. Patent Drafting

How Overstating Background Art Can Come Back to Hurt a U.S. Patent

Calling too much technology “prior art” or “conventional” can create admissions that later shape U.S. examination and validity disputes.

USPTO Practice

Why “No Motivation to Combine” Often Fails as a Standalone §103 Argument

A stronger §103 response tests the examiner’s reasoning, compatibility, expected success, and claim gaps—not just motivation to combine.

Cross-Border Practice

When a U.S. Examiner Says Your Claims Read Like a Translation: What Went Wrong?

Literal translation is not itself a §112 violation. The problem begins when grammar, antecedent basis, inconsistent naming, or unclear relationships make the claim boundaries hard to determine.

USPTO Practice

What Must a USPTO Examiner Show to Support an Obviousness Rejection?

A §103 rejection needs more than matched claim elements. The examiner must connect the prior-art facts to an articulated obviousness rationale.

USPTO Practice

Why the Examiner Should Be One of the First Things You Check in a USPTO Office Action

Examiner context can improve prosecution strategy, but it should guide communication and process—not replace claim, prior-art, and legal analysis.

USPTO Practice

A U.S. Patent Allowed Without an Office Action Is Not Always Good News

First-action allowance can be excellent news, but it should still trigger a claim, file-history, continuation, IDS, and issue-readiness audit.

USPTO Practice

Why More Chinese Patent Applications Need Adaptation Before U.S. Filing

A faithful translation can still leave a U.S. filing strategically brittle. Adaptation reviews claim architecture, disclosure support, terminology, priority, and amendment room before the record is fixed.

Patent AI

As Patent AI Gets Better, Expert Judgment Becomes More Valuable

As AI makes retrieval, comparison, and first drafts cheaper, expert value shifts toward verification, issue spotting, claim-scope judgment, and accountable decisions.

Patent AI

When Clients Use AI to Draft Invention Disclosures, Patent Counsel May Have More Work—not Less

AI can make invention disclosures cleaner and faster while increasing the need to verify technical provenance, inventorship, §112 support, and confidentiality.

Patent AI

How U.S. Patent Lawyers Actually Use AI—and Why Human Review Still Matters

The strongest patent-AI workflows use models for retrieval, comparison, drafting assistance, and QA—while keeping legal conclusions and professional responsibility with humans.

NEW
USPTO Practice

When Applicants Help Examiners Find Rejections: Managing IDS Strategy in U.S. Patent Prosecution

For Chinese applicants, IDS practice can feel like paying counsel to hand the examiner rejection material. The real discipline is earlier disclosure, smarter batching, duplicate control, and internal tracking before litigation risk appears.

NEW
Claim Drafting

When “About” Becomes Indefinite: A Patent Drafting Lesson from Enviro Tech v. Safe Foods

The Federal Circuit’s Enviro Tech decision shows how ordinary approximation language can invalidate claims when an amended numerical boundary is not anchored in the specification or prosecution history.

NEW
Trademark

Scheming Trademarks: How Bad-Faith Filings Trap Chinese Cross-Border Sellers on Amazon

Bad-faith trademark filings target Chinese Amazon sellers through brand-name hijacking, keyword squatting, and insider schemes. A practical guide to TTAB remedies, preemptive filing, and Amazon appeal strategies.

NEW
Portfolio Review

Patent Agent Liability: Who Bears the Risk When Cross-Border Prosecution Goes Wrong?

When patent prosecution fails through missed deadlines, translation errors, or inadequate searches, the liability chain between Chinese applicants, intermediary firms, and US agents becomes critical. Examining the legal framework and risk allocation strategies.

NEW
Portfolio Review

Patent Going Global: The Starting Point for Chinese Enterprises Entering International Markets

A practitioner’s roadmap for Chinese enterprises: portfolio audits, PCT vs. Paris Convention routes, multi-jurisdictional claim strategy, realistic budget planning, and practitioner selection criteria.

NEW · RULE CHANGE
USPTO Practice

No More Exceptions: The USPTO’s Final Rule Requiring U.S. Practitioner Representation for Foreign Applicants

Effective July 20, 2026: foreign patent applicants must be represented by a registered U.S. practitioner for required submissions and post-filing activity. Full breakdown of requirements, the ADS trap, defined exceptions, cost data, and what it means for Chinese firms.

Claim Construction

“Generally,” “Substantially,” and “Attached”: The Federal Circuit’s Lesson on Claim Modifier Language

The Federal Circuit reversed on all three disputed terms in Dürr v. EFC. What the decision teaches about approximation modifiers, structural relationship terms, prosecution disclaimer scope, and claim differentiation —in a single case.

USPTO Practice

PIER Pilot Program: What PCT Applicants Must Know in 2026

The USPTO PIER Pilot requires PCT national-phase applicants to make an early election. This guide explains the options, timing, PTA implications, and practical response issues.

USPTO Practice

Why Your Patent Abstract Matters More Than You Think: USPTO vs. EPO

Most practitioners treat the abstract as an afterthought. We argue that in cross-border prosecution —particularly when the same family is filed at both USPTO and EPO —the abstract's language can have downstream consequences for claim interpretation and prosecution history estoppel.

Office Action

Navigating § 112(a) New Matter Issues: A Practical Prosecution Guide

New matter rejections remain among the most technically demanding challenges in prosecution. This guide walks through the doctrinal framework from Ariad v. Eli Lilly and MPEP § 2163, with practical strategies for responding when the examiner has drawn a narrow interpretation of the original disclosure.

U.S. Patent Drafting

Why U.S. Patent Claims Usually Avoid Drawing Reference Numerals

Reference numerals are common and expressly non-limiting in Chinese claims. U.S. practice also permits them—so why do U.S. practitioners often remove them before filing?

Patent Translation

The Art of Patent Translation: Beyond Language into Legal Precision

A technically accurate translation can still fail in prosecution if the translator lacks familiarity with US claims practice. We examine what distinguishes legal-grade translation from language conversion —and why Chinese patent applicants need practitioners who understand both systems.

USPTO Practice

Overcoming a §101 Rejection in U.S. Patent Prosecution: A Practical Response Framework

A practical §101 response ties the examiner’s analysis, the claimed technological improvement, and the specification into one coherent eligibility story.

Patent Risk / FTO

Festo and the Cost of Claim Amendments: Prosecution History Estoppel in U.S. Patent Practice

A narrowing amendment can overcome an examiner and later restrict the doctrine of equivalents. Festo explains what was surrendered and why the prosecution record matters.

Office Action

How to Respond to a USPTO Final Office Action Without Abandoning Claims

A Final Office Action doesn't have to mean the end of the road. This article compares the strategic tradeoffs between filing an RCE, an After-Final Amendment, a Pre-Appeal Brief Request, and a Notice of Appeal —helping practitioners choose the right path based on rejection type and claim scope goals.

Cross-Border Practice

CNIPA Inventive Step vs. USPTO Obviousness: Different Analytical Structures, Different Drafting Risks

CNIPA’s three-step inventive-step method and U.S. Graham/KSR obviousness analysis address a related question through different structures—with real consequences for drafting and OA strategy.

U.S. Patent Drafting

Why “Characterized in That” Often Needs Reworking for U.S. Patent Claims

“Characterized in that” is a normal feature of Chinese and PCT two-part claims. In U.S. practice, however, preserving that structure can move the claim toward Jepson territory and create record consequences.

Claim Drafting

What Does “Configured To” Mean in a U.S. Patent Claim?

“Configured to” can require a real functional configuration rather than mere capability—but its limiting effect depends on claim context and disclosure.

EPO Practice

EPO Opposition Strategy: Building a Winning Prior Art Portfolio

EPO oppositions are won or lost on the quality of prior art selection and the framing of inventive step arguments under the Problem-Solution Approach. This article outlines how to systematically build a prior art portfolio and structure Art. 56 EPC arguments that survive oral proceedings.

U.S. Patent Drafting

Why “A” and “The” Matter in U.S. Patent Claims: Antecedent Basis for Chinese Applicants

In U.S. claims, “a” usually introduces an element and “the” or “said” refers back to it. The convention is simple, but literal translation and terminology drift can make the scope unclear.

Cross-Border Practice

Why a Software Patent That Works in China May Struggle in the United States

A software claim that clears CNIPA examination can still face a very different U.S. eligibility and disclosure analysis. The right response is not literal translation, but pre-filing legal-technical adaptation.

Patent AI

When AI Changes the Economics of Legal Work: How Patent Professionals Should Rethink Pricing and Value

AI weakens the link between professional value and hours spent. Patent practices can respond by pricing defined outcomes, expert judgment, verification, and accountability.

Patent AI

AI Cannot Be the Inventor: What the USPTO’s Current Position Means for Patent Practice

The USPTO’s revised AI-assisted inventorship guidance confirms that AI is a tool, not an inventor. What patent teams should document, verify, and preserve.

Patent AI

When Judges Get AI Wrong: What Legal AI Failures Teach Us About Expert Verification

Recent AI-related court errors show why legal AI needs human verification, source checking, domain rubrics, and accountable review—not blind trust in fluent output.

Patent AI

The USPTO’s AI Search Pilot Is Closed—What Should Applicants Learn from It?

The USPTO’s ASAP! automated prior-art search pilot closed in June 2026. Its design still offers useful lessons about earlier prior-art visibility and prosecution strategy.

USPTO Practice

Obviousness-Type Double Patenting in U.S. Patent Practice: Rules, Risks, and Strategy

ODP is not just a terminal-disclaimer formality. Cellect, Allergan, and 2026’s Ex parte Baurin make claim, term, and family strategy central.

Patent Risk / FTO

Global-Tech and Induced Infringement: Knowledge, Willful Blindness, and Patent Risk

Global-Tech requires knowledge for induced infringement and recognizes willful blindness only when high-probability belief is paired with deliberate avoidance of the facts.

Patent Risk / FTO

Patent Opinions After Halo: What They Can—and Cannot—Do for Willfulness Risk

Halo ended Seagate’s rigid objective gate, while §298 bars adverse inferences from not obtaining an opinion. Opinions still matter—but as evidence and decision tools, not automatic shields.

Restriction Practice

Restriction Requirements in U.S. Patent Prosecution: Rules, Strategy, and Response Options

Restriction affects election, traverse rights, withdrawn claims, rejoinder, divisionals, and later family strategy—not just which claims get examined first.

Patent Risk / FTO

eBay v. MercExchange: Why Patent Infringement Does Not Automatically Mean an Injunction

eBay rejected automatic patent injunctions and categorical denials alike. Permanent injunctions require the traditional four-factor equitable test.

§102 Novelty

How USPTO Examiners Analyze Novelty Under §102

Anticipation requires a legally available single reference that discloses every limitation, expressly or inherently, in the arrangement the claim requires.

Case Analysis

Lululemon v. Costco: How Layered IP Protection Creates a Brand Moat

Lululemon's lawsuit against Costco —design patents, registered trademarks, and trade dress combined in a single action —is a textbook case study in layered IP strategy. Direct lessons for Chinese brands building defensible market positions in the US.

Patent Risk / FTO

Phillips and U.S. Claim Construction: Why the Specification Matters

Phillips remains the core U.S. claim-construction framework: read claim language through the specification and prosecution history before leaning on dictionaries or experts.

Portfolio Review

PCT Strategy for Chinese Applicants: Maximizing Value at the National Phase

The PCT framework offers strategic leverage that many Chinese applicants underutilize. This article examines how to use the International Search Report, IPRP, and voluntary amendments under Rule 161 to shape claim scope before entering the US and European national phases.

CROSSVISION IP

Need Patent or IP Expertise Beyond the Articles?

CrossVision IP also supports Patent/IP subject-matter expert engagements, Chinese Patent Law and CNIPA analysis, AI evaluation and cross-border patent projects.